HomeCompareRCM vs XYLD

RCM vs XYLD: Dividend Comparison 2026

RCM yields 13.98% · XYLD yields 11.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RCM wins by $24.2K in total portfolio value
10 years
RCM
RCM
● Live price
13.98%
Share price
$14.31
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50.1K
Annual income
$3,323.55
Full RCM calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
11.20%
Share price
$38.36
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$3,351.03
Full XYLD calculator →

Portfolio growth — RCM vs XYLD

📍 RCM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCMXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCM + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCM pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCM
Annual income on $10K today (after 15% tax)
$1,187.98/yr
After 10yr DRIP, annual income (after tax)
$2,825.02/yr
XYLD
Annual income on $10K today (after 15% tax)
$952.37/yr
After 10yr DRIP, annual income (after tax)
$2,848.38/yr
At 15% tax rate, XYLD beats the other by $23.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCM + XYLD for your $10,000?

RCM: 50%XYLD: 50%
100% XYLD50/50100% RCM
Portfolio after 10yr
$38.0K
Annual income
$3,337.28/yr
Blended yield
8.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RCM right now

RCM
Analyst Ratings
13
Buy
9
Hold
Consensus: Buy
Price Target
$17.11
+19.6% upside vs current
Range: $14.00 — $25.00
Altman Z
1.7
Piotroski
3/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCM buys
0
XYLD buys
0
No recent congressional trades found for RCM or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCMXYLD
Forward yield13.98%11.20%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$50.1K$25.9K
Annual income after 10y$3,323.55$3,351.03
Total dividends collected$23.2K$20.2K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RCM vs XYLD ($10,000, DRIP)

YearRCM PortfolioRCM Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$12,098$1,397.62$10,840$1,120.44+$1.3KRCM
2$14,525$1,580.18$11,786$1,249.59+$2.7KRCM
3$17,314$1,773.08$12,854$1,397.78+$4.5KRCM
4$20,502$1,975.37$14,063$1,568.33+$6.4KRCM
5$24,123$2,185.99$15,434$1,765.19+$8.7KRCM
6$28,215$2,403.82$16,995$1,993.14+$11.2KRCM
7$32,818$2,627.68$18,777$2,257.95+$14.0KRCM
8$37,972$2,856.39$20,818$2,566.58+$17.2KRCM
9$43,719$3,088.74$23,163$2,927.50+$20.6KRCM
10$50,102$3,323.55$25,865$3,351.03+$24.2KRCM

RCM vs XYLD: Complete Analysis 2026

RCMStock

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.

Full RCM Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this RCM vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCM vs SCHDRCM vs JEPIRCM vs ORCM vs KORCM vs MAINRCM vs QYLDRCM vs JEPQRCM vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.